Neoadjuvant cetuximab, capecitabine, and radiotherapy (RT) in locally advanced resectable rectal cancer: results of a phase II trial

被引：0
|
作者：
Velenik, V. [1 ]
Ocvirk, J. [1 ]
Oblak, I. [1 ]
Anderluh, F. [1 ]
机构：
[1] Inst Oncol, Ljubljana, Slovenia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15029
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II XERT trial: Neoadjuvant cetuximab, capecitabine and radiotherapy (RT) in locally advanced resectable rectal cancer
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 327 - 327
  • [2] RESULTS FROM THE PHASE II XERT STUDY: NEOADJUVANT CETUXIMAB, CAPECITABINE, AND RADIOTHERAPY (RT) IN LOCALLY ADVANCED RESECTABLE RECTAL CANCER
    Velenik, V.
    Ocvirk, J.
    Oblak, I
    Anderluh, F.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 109 - 109
  • [3] A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    [J]. EJSO, 2010, 36 (03): : 244 - 250
  • [4] Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study
    Sun, Pei-Long
    Li, Bing
    Ye, Qi-Fa
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (10) : 1325 - 1332
  • [5] Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study
    Pei-Long Sun
    Bing Li
    Qi-Fa Ye
    [J]. International Journal of Colorectal Disease, 2012, 27 : 1325 - 1332
  • [6] PHASE II TRIAL OF NEOADJUVANT BEVACIZUMAB, CAPECITABINE, AND RADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER
    Crane, Christopher H.
    Eng, Cathy
    Feig, Barry W.
    Das, Prajnan
    Skibber, John M.
    Chang, George J.
    Wolff, Robert A.
    Krishnan, Sunil
    Hamilton, Stanley
    Janjan, Nora A.
    Maru, Dipen M.
    Ellis, Lee M.
    Rodriguez-Bigas, Miguel A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 824 - 830
  • [7] CETUXIMAB IN COMBINATION WITH CAPECITABINE, IRINOTECAN, AND RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER: RESULTS OF A PHASE II MARGIT TRIAL
    Horisberger, Karoline
    Treschl, Anne
    Mai, Sabine
    Barreto-Miranda, Manuel
    Kienle, Peter
    Stroebel, Philipp
    Erben, Philipp
    Woernle, Christoph
    Dinter, Dietmar
    Kaehler, Georg
    Hochhaus, Andreas
    Post, Stefan
    Willeke, Frank
    Wenz, Frederik
    Hofheinz, Ralf-Dieter
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (05): : 1487 - 1493
  • [8] Preoperative Radiotherapy, Capecitabine and Cetuximab for Locally Advanced Rectal Cancer - Long Term Results of the XERT Phase II Trial
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S404 - S404
  • [9] Neoadjuvant bevacizumab, capecitabine, and radiotherapy in locally advanced rectal cancer: Interim results of a phase II CRAB trial.
    Velenik, V.
    Ocvirk, J.
    Omejc, M.
    Music, M.
    Anderluh, F.
    Oblak, I.
    Edhemovic, I.
    Bracelj, E.
    Kropivnik, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: Prospective phase II trial
    Velenik, Vaneja
    Anderluh, Franc
    Oblak, Irena
    Strojan, Primoz
    Zakotnik, Branko
    [J]. CROATIAN MEDICAL JOURNAL, 2006, 47 (05) : 693 - 700
12345